ISSN-registered · Peer-reviewed · Open Access
JournalsAboutContact
Submit Manuscript
Research Topic

NSCLC

2 article(s) on this topic across our journals.

Erlotinib plus bevacizumab vs erlotinib monotherapy as first-line treatment for advanced EGFR mutation-positive non-squamous non-small-cell lung cancer: Survival follow-up results
The Clinical Lung Cancer

Developments and Difficulties of Messenger RNA Vaccines in NSCLC Therapy
Advances in Vaccines